Go to dennemeyer.com
Posts filed in patents

Im Mai 2017 stellte Dennemeyer gemeinsam mit dem 2b AHEAD-ThinkTank die Studie „The future of Intellectual Property“ in den Münchner Highlight Towers vor.

Opposition procedures before the EPO and the JPO have enough differences to put even experienced professionals in difficulty. Read more (in English & Japanese).

Dr. Malte Köllner from Dennemeyer & Associates has again been selected among Germany’s best lawyers 2017.

The new branch office assists our existing clients with protecting their IP rights in Africa.

“Thinking outside the confines of the continental map”, discover how validation agreements might re-shape the world of European patent applications.

By 2030 the exploitation of IPR will no longer be what it is today. Technology might be the solution, but the interaction with the client is also increasing.

Come meet us at INTA Annual Meeting 2017 in Barcelona, Spain, and discover how Dennemeyer can help you successfully manage your Intellectual Property portfolio.

Amendments to the claims of European patent applications and patents are a delicate issue. Find out more about recent developments of the related case law.

When considering an “ASEAN IP strategy”, one must consider what is meant by “ASEAN” and “Asia”. These terms can be loosely interpreted or used interchangeably.

Identifying the value and purpose of an IP asset at any point in its lifecycle is critical to creating improvements to a company or law firm's operation.

Our 2017 US Forum Series focusses on “The Future of IP and Technology Law”. And it is coming to a city near you this spring.

Höchste Zeit, den Kreis der Zuschauer zu erweitern: Wegen des großen Erfolgs der Reihe veröffentlicht Dennemeyer künftig Videos der einzelnen Themen der Reihe.

The new branch office assists our existing clients with protecting their IP rights in the Russian Federation and Eurasia.

Our 2017 series of workshops is discussing various strategic and legal aspects of Trademarks and Patents.

According to the EPO, a patent claim directed to a plant obtained in an essentially biological processes can be granted under the EPC.